We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Gold Nanoparticle-Based Electrode Marks Breakthrough in Urinalysis Disease Detection Methodology

By LabMedica International staff writers
Posted on 25 Feb 2022
Print article
Image: Electroanalytical technique uses gold-containing ternary nanocomposites (Photo courtesy of Unsplash)
Image: Electroanalytical technique uses gold-containing ternary nanocomposites (Photo courtesy of Unsplash)

Using gold-containing ternary nanocomposites, researchers have developed a novel electroanalytical technique with key diagnostic implications.

The novel electroanalytical technique developed by researchers at Xi'an Jiaotong University (Xi'an, China) permits the co-detection of dopamine (DA) and uric acid (UA) in urine samples even in the presence of ascorbic acid (AA). Urinalysis, or the detection and estimation of various pathophysiological substances in urine samples, is routinely recommended for disease diagnosis. Increased levels of UA, for instance, may indicate underlying kidney or heart disease. Similarly, an increase in the urinary levels of dopamine DA may indicate the presence of neurological disorders like neuroblastoma or Parkinson's disease. Because pathology labs need to simultaneously determine the urinary levels of multiple substances, techniques that permit such co-detection are necessary. However, such co-analyses sometimes present with technical hurdles. In the case of urine samples, the relatively higher concentrations of AA in urine interferes with the simultaneous detection of DA and UA, both of which are present at relatively lower levels.

To resolve this challenge, the researchers combined a nanocomposite mixture, which had an average grain size of 10-9 meters or more, made up of gold nanoparticles (AuNPs), a special (conducting) polymer, and electrochemically-treated graphene oxide over a conventional glassy carbon electrode (GCE), to get a superior electrode. A GCE combines the properties of glass with those of graphite. However, it needed to be modified for the selective and simultaneous detection of DA and UA in the presence of high concentrations of AA. The researchers employed a combination of chemical and electrochemical methods. They started with poly(3,4-ethylenedioxythiophene), or PEDOT, which is a highly conductive polymer with much promise in the field of biosensors.

The PEDOT-AuNPs were chemically synthesized from chloroauric acid and 3,4-ethylenedioxythiophene at room temperature. The addition of graphene oxide (GO) resulted in the formation of a homogeneous suspension of PEDOT-AuNPs-GO. This suspension was then dropped onto the surface of a GCE and dried. Finally, following an electrochemical procedure, the nanomaterial OPEDOT-AuNPs-ERGO/GCE was successfully fabricated and readied for bioanalytical measurements. When used, the modified electrode could simultaneously detect extremely tiny amounts of DA (1 mM) and UA (5 mM) under physiological conditions, even in the presence of a large excess (1.0 mM) of AA. The research team foresees a bright future for this novel nanomaterial-based application, especially in clinical and diagnostic setups. Future studies are certainly required, but this novel nanocomposite electrode has strong potential to become the gold standard for diagnostics in pathology laboratories.

"PEDOT can be overoxidized to obtain OPEDOT, whose hydrophilicity and unique properties make it useful in electroanalytical applications," said Associate Professor Dongdong Zhang of Xi'an Jiaotong University who led the research team. "However, since OPEDOT is not as good an electrical conductor or catalyst, it is modified with suitable nanomaterials, in this case, gold nanoparticles."

"Our novel, graphene-based, ternary composite, with its advantageous features, is a promising candidate for electroanalytical and clinical applications," added Dr. Zhang.

Related Links:
Xi'an Jiaotong University 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.